Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics
Mollie H. Wright(National Cancer Institute), Lyuba Varticovski(National Cancer Institute)
Cited by 660
Related Papers
HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair
|Molecular Cancer Therapeutics|2008|82